Rodrigo R. Muhoz, MD, William D. Tap, MD

Articles by Rodrigo R. Muhoz, MD, William D. Tap, MD

Novel Molecular Targets for Drug Development in Non-GIST Sarcomas

ByRodrigo R. Muhoz, MD, William D. Tap, MD

February 26th 2016

In this review, Rodrigo R. Muhoz, MD, William D. Tap, MD, and Sandra P. D'Angelo, MD address the emerging therapeutic strategies aimed at specific molecular targets that could potentially change the approach to patients with soft-tissue sarcomas.

Latest Updated Articles

Novel Molecular Targets for Drug Development in Non-GIST Sarcomas
Published: February 26th 2016 | Updated:

Rodrigo R. Muhoz, MD, William D. Tap, MD

Articles by Rodrigo R. Muhoz, MD, William D. Tap, MD

Novel Molecular Targets for Drug Development in Non-GIST Sarcomas

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update